Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers-Reference-Cited by-同舟云学术

Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers

Published:2017-08-15 Issue:16 Volume:60 Page:7043-7066
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Anthony Nahoum G.¹,Baiget Jessica¹,Berretta Giacomo¹,Boyd Marie¹,Breen David²,Edwards Joanne³,Gamble Carly¹,Gray Alexander I.¹,Harvey Alan L.¹,Hatziieremia Sophia¹,Ho Ka Ho¹,Huggan Judith K.¹,Lang Stuart²,Llona-Minguez Sabin¹^ORCID,Luo Jia Lin¹,McIntosh Kathryn¹,Paul Andrew¹,Plevin Robin J.¹,Robertson Murray N.¹^ORCID,Scott Rebecca¹,Suckling Colin J.²,Sutcliffe Oliver B.¹^ORCID,Young Louise C.¹,Mackay Simon P.¹^ORCID

Affiliation:

1. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United Kingdom

2. WestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland, United Kingdom

3. Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, Scotland, United Kingdom

Funder

Prostate Cancer UK

Cancer Research UK

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00484

Reference47 articles.

1. Nuclear factor-κB in cancer development and progression

2. NF-κB, an Evolutionarily Conserved Mediator of Immune and Inflammatory Responses